SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-97-003538
Filing Date
1997-10-16
Accepted
1997-10-16 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH TARGET, S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 BB BIOTECH AG SC 13D RE: CV THERAPEUTICS SC 13D 105720
  Complete submission text file 0000950133-97-003538.txt   107797
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 4158129300
CV THERAPEUTICS INC (Subject) CIK: 0000921506 (see all company filings)

IRS No.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47551 | Film No.: 97696406
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000